Rxivist logo

Chondroitin sulfate elicits systemic pathogenesis in mice by interfering with gut microbiota homeostasis

By Tao Liao, Yan-Ping Chen, Shui-Qing Huang, Li-Li Tan, Chang-Qing Li, Xin-An Huang, Qin Xu, Qi Wang, Qing-Ping Zeng

Posted 27 May 2017
bioRxiv DOI: 10.1101/142588

Whether chondroitin sulfate (CS), a common ingredient naturally occurring in livestock and poultry products, improves osteoarthritis remains debating. Here, we show for the first time that CS induces steatogenesis, atherogenesis, and dementia-like pathogenesis in mice. Gut microbiome analysis revealed the sulfatase-secreting bacteria Rikenella and the sulfate-reducing bacteria Desulfovibrio are enriched. Surprisingly, berberine use boosts CS-induced multi-loci inflammatory manifestations by further increasing the abundance of Rikenella and Desulfovibrio, whereas cephalosporin reinforces the colon mucus barrier via flourishing Akkermansia muciniphila and upregulating mucin expression. Mechanistically, berberine aggravates mucus lining injury by prompting mucin degradation, endotoxin leakage, neutralizing antibody induction, pro-inflammatory cytokine burst, lactic acid accumulation and energy currency depletion in multiple organs and tissues. Taken together, CS evokes the early-phase pathogenesis towards steatohepatitis, atherosclerosis, and dementia upon augment gut opportunistic infection, and a sustained antibiotic monotherapy does not deprive the risk of CS-driven systemic inflammatory disorders.

Download data

  • Downloaded 904 times
  • Download rankings, all-time:
    • Site-wide: 26,605
    • In pharmacology and toxicology: 152
  • Year to date:
    • Site-wide: 89,561
  • Since beginning of last month:
    • Site-wide: 77,680

Altmetric data

Downloads over time

Distribution of downloads per paper, site-wide